Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Pharmacokinet Exp Ther 2023, Vol 7(5): 5
  • DOI: 10.4172/jpet.1000200

Resistance to Antifungal Drugs Evolution, Causes, and Consequences

Kali M Revie*
Department of Molecular Genetics, Toronto, Canada
*Corresponding Author : Kali M Revie, Department of Molecular Genetics, Toronto, Canada, Email: Kmr990@gmail.com

Received Date: Sep 30, 2023 / Published Date: Oct 31, 2023

Abstract

Resistance to antifungal drugs is a growing concern in the field of medical mycology and public health. As the use of antifungal agents becomes more widespread, fungal pathogens are evolving mechanisms to evade their effects, rendering once-effective treatments ineffective. This evolution of resistance is a multifaceted process driven by various factors, including genetic mutations, overuse and misuse of antifungal agents, and environmental pressures. In this review, we explore the current state of antifungal drug resistance, its underlying causes, and the potential consequences for patients and healthcare systems. Understanding the dynamics of antifungal drug resistance is crucial for developing strategies to mitigate its impact and preserve the efficacy of these essential therapies.

Citation: Revie KM (2023) Resistance to Antifungal Drugs Evolution, Causes, andConsequences. J Pharmacokinet Exp Ther 7: 200. Doi: 10.4172/jpet.1000200

Copyright: © 2023 Revie KM. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top